Installation
About
Implements maximum likelihood methods for evaluating the durability of vaccine efficacy in a randomized, placebo-controlled clinical trial with staggered enrollment of participants and potential crossover of placebo recipients before the end of the trial. Lin, D. Y., Zeng, D., and Gilbert, P. B. (2021) doi:10.1093/cid/ciab226 and Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021) doi:10.1093/cid/ciab630.
Key Metrics
Downloads
Yesterday | 18 0% |
Last 7 days | 67 -12% |
Last 30 days | 287 -13% |
Last 90 days | 1.117 +32% |
Last 365 days | 3.449 +3% |